Healthcare - Biotechnology - NASDAQ - US
$ 9.49
-3.16 %
$ 462 M
Market Cap
-2.74
P/E
Price Target
Average
138.85%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
20.23%
Net Income
Estimate
22.02%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
KalVista Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for KALV of $22.7 , with forecasts ranging from a low of $20 to a high of $28 .
KALV Lowest Price Target
Wall Street Target
20 USD
110.75%
KALV Average Price Target
Wall Street Target
22.7 USD
138.85%
KALV Highest Price Target
Wall Street Target
28 USD
195.05%
REVENUE FORECAST
Revenue Forecast Chart KALV
EBIT FORECAST
EBIT Forecast Chart KALV
NET INCOME FORECAST
Net Income Chart KALV